✨
AI Summary
- Kite Pharma reduced median turnaround time for Yescarta.
- Achieved FDA approval for manufacturing process changes.
- Lessons learned from FDA collaboration and scaling cell therapies.
Guests on This Episode
CM
Christopher McDonald
7 podcast appearances